Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MANKIND PHARMA vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MANKIND PHARMA GLENMARK PHARMA MANKIND PHARMA/
GLENMARK PHARMA
 
P/E (TTM) x 48.1 -42.0 - View Chart
P/BV x 10.9 5.3 205.2% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 MANKIND PHARMA   GLENMARK PHARMA
EQUITY SHARE DATA
    MANKIND PHARMA
Mar-24
GLENMARK PHARMA
Mar-24
MANKIND PHARMA/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs2,375974 243.8%   
Low Rs1,241464 267.1%   
Sales per share (Unadj.) Rs258.0418.6 61.6%  
Earnings per share (Unadj.) Rs48.5-64.9 -74.7%  
Cash flow per share (Unadj.) Rs58.4-44.3 -132.0%  
Dividends per share (Unadj.) Rs02.50 0.0%  
Avg Dividend yield %00.3 0.0%  
Book value per share (Unadj.) Rs233.2277.5 84.0%  
Shares outstanding (eoy) m400.59282.19 142.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.01.7 407.8%   
Avg P/E ratio x37.3-11.1 -336.4%  
P/CF ratio (eoy) x30.9-16.3 -190.4%  
Price / Book Value ratio x7.82.6 299.1%  
Dividend payout %0-3.9 -0.0%   
Avg Mkt Cap Rs m724,164202,964 356.8%   
No. of employees `000NANA-   
Total wages/salary Rs m22,74728,681 79.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m103,348118,131 87.5%  
Other income Rs m2,8098,400 33.4%   
Total revenues Rs m106,156126,531 83.9%   
Gross profit Rs m25,5182,944 866.9%  
Depreciation Rs m3,9835,819 68.4%   
Interest Rs m3505,160 6.8%   
Profit before tax Rs m23,994365 6,574.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4,57618,673 24.5%   
Profit after tax Rs m19,418-18,309 -106.1%  
Gross profit margin %24.72.5 990.8%  
Effective tax rate %19.15,116.7 0.4%   
Net profit margin %18.8-15.5 -121.2%  
BALANCE SHEET DATA
Current assets Rs m65,65574,281 88.4%   
Current liabilities Rs m21,19758,186 36.4%   
Net working cap to sales %43.013.6 315.7%  
Current ratio x3.11.3 242.6%  
Inventory Days Days9731 311.1%  
Debtors Days Days30057 521.7%  
Net fixed assets Rs m53,14658,808 90.4%   
Share capital Rs m401282 142.0%   
"Free" reserves Rs m92,99878,015 119.2%   
Net worth Rs m93,39878,297 119.3%   
Long term debt Rs m2490-   
Total assets Rs m118,829133,089 89.3%  
Interest coverage x69.51.1 6,487.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.9 98.0%   
Return on assets %16.6-9.9 -168.4%  
Return on equity %20.8-23.4 -88.9%  
Return on capital %26.07.1 368.4%  
Exports to sales %6.30-   
Imports to sales %00-   
Exports (fob) Rs m6,495NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6,49532,207 20.2%   
Fx outflow Rs m1,64919,636 8.4%   
Net fx Rs m4,84612,571 38.5%   
CASH FLOW
From Operations Rs m21,524-2,654 -810.9%  
From Investments Rs m-20,81745,609 -45.6%  
From Financial Activity Rs m53-39,061 -0.1%  
Net Cashflow Rs m7722,152 35.9%  

Share Holding

Indian Promoters % 74.9 46.7 160.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 22.3 36.3 61.3%  
FIIs % 12.4 23.1 53.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.1 53.4 47.1%  
Shareholders   163,854 193,949 84.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MANKIND PHARMA With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on MANKIND PHARMA vs Glenmark Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

MANKIND PHARMA vs Glenmark Pharma Share Price Performance

Period MANKIND PHARMA Glenmark Pharma S&P BSE HEALTHCARE
1-Day -0.04% 1.01% 1.23%
1-Month -0.62% -12.07% -0.24%
1-Year 31.92% 90.62% 43.62%
3-Year CAGR 21.46% 46.67% 20.35%
5-Year CAGR 12.37% 33.91% 26.24%

* Compound Annual Growth Rate

Here are more details on the MANKIND PHARMA share price and the Glenmark Pharma share price.

Moving on to shareholding structures...

The promoters of MANKIND PHARMA hold a 74.9% stake in the company. In case of Glenmark Pharma the stake stands at 46.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of MANKIND PHARMA and the shareholding pattern of Glenmark Pharma.

Finally, a word on dividends...

In the most recent financial year, MANKIND PHARMA paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at -3.9%.

You may visit here to review the dividend history of MANKIND PHARMA, and the dividend history of Glenmark Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.